-transparent.png){kind=logo}
Although the therapeutic administration of lithium in the psychiatric setting has been associated with various renal side effects, only a few reported cases have suggested a possible link to glomerular disease. We report two patients who, while taking lithium, developed heavy proteinuria caused by minimal change disease and acute renal insufficiency attributable to acute tubular necrosis. These clinical findings resolved on discontinuation of the drug, suggesting a role for lithium in their development. We also postulate that lithium, with its unique properties as a modulator of the phosphoinositol pathway, may play a key role in the pathogenesis of minimal change disease.
V K Tam, and
J Green, and
J Schwieger, and
A H Cohen
September 1997,
The American journal of psychiatry,
V K Tam, and
J Green, and
J Schwieger, and
A H Cohen
May 1981,
Clinical nephrology,
V K Tam, and
J Green, and
J Schwieger, and
A H Cohen
June 1985,
Medicina clinica,
V K Tam, and
J Green, and
J Schwieger, and
A H Cohen
June 2007,
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
V K Tam, and
J Green, and
J Schwieger, and
A H Cohen
May 2001,
Medicina clinica,
V K Tam, and
J Green, and
J Schwieger, and
A H Cohen
January 1980,
Annals of internal medicine,
V K Tam, and
J Green, and
J Schwieger, and
A H Cohen
April 1985,
Canadian Medical Association journal,
V K Tam, and
J Green, and
J Schwieger, and
A H Cohen
December 1997,
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
V K Tam, and
J Green, and
J Schwieger, and
A H Cohen
January 1990,
Presse medicale (Paris, France : 1983),
V K Tam, and
J Green, and
J Schwieger, and
A H Cohen
October 2003,
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
